Chemical agents extracted from the root of the hydrangea plant are a safe and effective alternative to current treatments for immune-related medical conditions. Researchers have discovered, for example, that the medication halofuginone, derived from hydrangea root, keeps the body from producing harmful white blood cells that are commonly associated with immune system diseases. Happily, it can do this without interfering with immune system functioning. Orphan Drug Status
Halofuginone has recently been given FDA Orphan Drug Status for treating a condition called scleroderma. Scleroderma is an autoimmune condition that attacks the connective tissues of the body, stimulating increased production of collagen type 1. The excess collagen leads to disfigurement, and worse, it can be deadly. The current uses of halofuginone are relatively limited considering the many promising uses for the medicine. The Future